InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,556.62
(
0.86%
)
US TECH 100
19,819.40
(
0.91%
)
Dow Jones
39,249.34
(
-0.15%
)
Brent Oil
86.86
(
-0.54%
)
Bitcoin
56,715.70
(
-0.46%
)
Post# of 252491
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

turtlepower

Send PM Follow Ignore
Followers 1
Posts 1114
Boards Moderated 0
Alias Born 04/07/2009

turtlepower

Re: biomaven0 post# 139046

Friday, 03/23/2012 8:31:10 AM

Friday, March 23, 2012 8:31:10 AM

Post# of 252491
XNPT - The PHN indication is based on a single PII trial. That appears to satisfy the 505b2 pathway to some respect. The only question I have is about the dosage. The recommended dosage for Horizant is 600 mg daily. The PHN approval is for 600mg BID. Will this be an issue especially with the cancer issue they had earlier.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up